Developing biological treatments for metabolic and brain-related diseases
Metabolic disorders disrupt how the body obtains or uses energy, creating imbalances in substances needed for health. Some metabolic diseases also damage nerves, causing pain, weakness and difficulty walking. If the metabolic problem cannot be controlled, nerve damage may continue.
Aperio Therapeutics is developing a long-acting biological treatment targeting energy deficiency and cellular signalling. Its preclinical work focuses on medicines for diseases at the intersection of metabolism and the brain.
What stands out about Aperio Therapeutics
Reports support from the aws Preseed - Deeptech grant, alongside investors and the BioInnovation Institute.
Selected for BII's Venture Lab through its collaboration with XISTA, providing scientific and venture-building support.
Identified by XISTA as an academic spinout developing biological treatments for diseases related to metabolic physiology.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.